Commonly reported side effects include mild injectionsite irritation, transient soreness, or fatigue, while more serious or systemic effects are less defined due to limited largescale human data
So CagriSema applies two independent signals that both converge on decelerating the stomach: cagrilintide via amylin/AMY receptors in the area postrema and its vagal output, and semaglutide via GLP-1 receptors on vagal afferents and in the brainstem
In certain embodiments, any controlled-release otic formulation described herein increases the exposure time of an active agent and decreases the C max in otic fluids (e.g., endolymph and/or perilymph) by about 40%, about 30%, about 20%, or about 10%, compared to a formulation that is not a controlled-release otic formulation
[Google Scholar] [PubMed] [CrossRef] 72
The key is to avoid repeated freeze-thaw cycles